Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure

NCT02653482 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

263

Enrollment

OTHER

Sponsor class

Conditions

Chronic Heart Failure With Reduced Systolic Function

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin matching placebo

Sponsor

Saint Luke's Health System